On Sep 8, 2021 Haemalogix closed a Venture – Series Unknown round and raised A$10,000,000 from Platinum Asset Management, featuring lead investors Platinum Asset Management.

About the company: Haemalogix is located at Australia, Oceania.
“HaemaLogiX is researching immune based treatments (Monoclonal Antibodies, CAR T cell therapies and Bispecific antibodies) that target unique antigens on malignant cells to treat patients suffering from blood cancers (Multiple Myeloma) and other life-threatening diseases (AL Amyloidosis).”

Company website: http://www.haemalogix.com